Literature DB >> 21514412

Mitochondrial biogenesis drives tumor cell proliferation.

Ubaldo E Martinez-Outschoorn1, Stephanos Pavlides, Federica Sotgia, Michael P Lisanti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21514412      PMCID： PMC3081148          DOI： 10.1016/j.ajpath.2011.03.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  31 in total

1.  Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells.

Authors:  Ubaldo E Martinez-Outschoorn; Renee M Balliet; Dayana B Rivadeneira; Barbara Chiavarina; Stephanos Pavlides; Chenguang Wang; Diana Whitaker-Menezes; Kristin M Daumer; Zhao Lin; Agnieszka K Witkiewicz; Neal Flomenberg; Anthony Howell; Richard G Pestell; Erik S Knudsen; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

2.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.

Authors:  Frank Weinberg; Robert Hamanaka; William W Wheaton; Samuel Weinberg; Joy Joseph; Marcos Lopez; Balaraman Kalyanaraman; Gökhan M Mutlu; G R Scott Budinger; Navdeep S Chandel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

3.  HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis.

Authors:  Barbara Chiavarina; Diana Whitaker-Menezes; Gemma Migneco; Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Anthony Howell; Herbert B Tanowitz; Mathew C Casimiro; Chenguang Wang; Richard G Pestell; Philip Grieshaber; Jaime Caro; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-09-04       Impact factor: 4.534

Review 4.  The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.

Authors:  Stephen J Ralph; Sara Rodríguez-Enríquez; Jiri Neuzil; Emma Saavedra; Rafael Moreno-Sánchez
Journal:  Mol Aspects Med       Date:  2010-03-02

5.  Effects of mitochondrial gene deletion on tumorigenicity of metastatic melanoma: reassessing the Warburg effect.

Authors:  Michael V Berridge; An S Tan
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

Review 6.  Cancer metabolism: the Warburg effect today.

Authors:  Leonardo M R Ferreira
Journal:  Exp Mol Pathol       Date:  2010-09-08       Impact factor: 3.362

7.  Expression of mitochondrial transcription factor A in endometrial carcinomas: clinicopathologic correlations and prognostic significance.

Authors:  Naoyuki Toki; Seiji Kagami; Tomoko Kurita; Toshinori Kawagoe; Yusuke Matsuura; Toru Hachisuga; Atsuji Matsuyama; Hiroshi Hashimoto; Hiroto Izumi; Kimitoshi Kohno
Journal:  Virchows Arch       Date:  2010-03-16       Impact factor: 4.064

8.  PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect.

Authors:  Chi V Dang
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

9.  The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.

Authors:  Stephanos Pavlides; Diana Whitaker-Menezes; Remedios Castello-Cros; Neal Flomenberg; Agnieszka K Witkiewicz; Philippe G Frank; Mathew C Casimiro; Chenguang Wang; Paolo Fortina; Sankar Addya; Richard G Pestell; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2009-12-05       Impact factor: 4.534

10.  Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation.

Authors:  Valentina Fogal; Adam D Richardson; Priya P Karmali; Immo E Scheffler; Jeffrey W Smith; Erkki Ruoslahti
Journal:  Mol Cell Biol       Date:  2010-01-25       Impact factor: 4.272
View more
  29 in total

1.  2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells.

Authors:  Magdalena Gorska-Ponikowska; Alicja Kuban-Jankowska; Stephan A Eisler; Ugo Perricone; Giosuè Lo Bosco; Giampaolo Barone; Stephan Nussberger
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

2.  Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells.

Authors:  Ubaldo E Martinez-Outschoorn; Richard G Pestell; Anthony Howell; Mark L Tykocinski; Fnu Nagajyothi; Fabiana S Machado; Herbert B Tanowitz; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

3.  The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis.

Authors:  G G Sun; Y D Wang; Y J Cheng; W N Hu
Journal:  Mol Biol Rep       Date:  2014-07-02       Impact factor: 2.316

4.  Enhancement of mitochondrial biogenesis and paradoxical inhibition of lactate dehydrogenase mediated by 14-3-3η in oncocytomas.

Authors:  Jie Feng; Qi Zhang; Chuzhong Li; Yang Zhou; Sida Zhao; Lichuan Hong; Qi Song; Shenyuan Yu; Chunxiu Hu; Herui Wang; Chengyuan Mao; Matthew J Shepard; Shuyu Hao; Gifty Dominah; Mitchell Sun; Hong Wan; Deric M Park; Mark R Gilbert; Guowang Xu; Zhengping Zhuang; Yazhuo Zhang
Journal:  J Pathol       Date:  2018-05-29       Impact factor: 7.996

5.  Potential interference of aluminum chlorohydrate with estrogen receptor signaling in breast cancer cells.

Authors:  Vyron A Gorgogietas; Ioannis Tsialtas; Natalie Sotiriou; Vasiliki C Laschou; Aikaterini G Karra; Demetres D Leonidas; George P Chrousos; Evagelia Protopapa; Anna-Maria G Psarra
Journal:  J Mol Biochem       Date:  2018

6.  BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma.

Authors:  G G Sun; Y D Wang; Y J Cheng; W N Hu
Journal:  Tumour Biol       Date:  2014-06-27

Review 7.  Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery.

Authors:  Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Federica Sotgia
Journal:  Cell Cycle       Date:  2013-07-30       Impact factor: 4.534

8.  The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.

Authors:  G G Sun; Y F Lu; Y J Cheng; W N Hu
Journal:  Tumour Biol       Date:  2013-11-22

9.  Compartment-specific activation of PPARγ governs breast cancer tumor growth, via metabolic reprogramming and symbiosis.

Authors:  Paola Avena; Wanda Anselmo; Diana Whitaker-Menezes; Chenguang Wang; Richard G Pestell; Rebecca S Lamb; James Hulit; Ivan Casaburi; Sebastiano Andò; Ubaldo E Martinez-Outschoorn; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2013-04-10       Impact factor: 4.534

10.  BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.

Authors:  S H Sheng; C M Zhao; G G Sun
Journal:  Tumour Biol       Date:  2013-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.